Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 271,807 | 97,608 | 61,349 | 54,876 | 62,919 |
| Marketable Securities | 105,359 | 101,096 | 130,180 | 121,581 | 139,357 |
| Receivables | 36,127 | 8,671 | 10,336 | 10,705 | 11,103 |
| TOTAL | $415,824 | $210,683 | $205,330 | $190,863 | $215,913 |
| Non-Current Assets | |||||
| PPE Net | 22,819 | 23,872 | 25,422 | 24,943 | 25,780 |
| Intangibles | 4,059 | 4,324 | 4,589 | 4,854 | 5,120 |
| Other Non-Current Assets | 20,875 | 20,875 | 20,875 | 20,875 | 20,875 |
| TOTAL | $47,753 | $49,071 | $50,886 | $50,672 | $51,775 |
| Total Assets | $463,577 | $259,754 | $256,216 | $241,535 | $267,688 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,895 | 5,494 | 7,433 | 3,150 | 3,985 |
| Accrued Expenses | 17,345 | 7,311 | 10,348 | 11,908 | 11,209 |
| Other current liabilities | 579 | 538 | 518 | 492 | 496 |
| TOTAL | $29,589 | $23,113 | $23,789 | $18,615 | $19,553 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,770 | 9,770 | 5,490 | 3,065 | 3,863 |
| Other Non-Current Liabilities | 250 | 400 | 551 | 701 | 816 |
| TOTAL | $17,348 | $19,941 | $26,059 | $22,564 | $22,768 |
| Total Liabilities | $46,937 | $43,054 | $49,848 | $41,179 | $42,321 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,815 | 59,358 | 54,973 | 53,051 | 52,813 |
| Common Shares | 7 | 5 | 5 | 5 | 5 |
| Retained earnings | -393,158 | -390,936 | -369,059 | -353,078 | -323,977 |
| Other shareholders' equity | -28 | 2 | -16 | 20 | 46 |
| TOTAL | $416,640 | $216,700 | $206,368 | $200,356 | $225,367 |
| Total Liabilities And Equity | $463,577 | $259,754 | $256,216 | $241,535 | $267,688 |